1-8 of 8
Munevver Cinar
Close
Sort by
Journal Articles

Development of First in Class DNA-Zip Code Drug Conjugate (ZDC) in Multiple Myeloma

Andrey Pisarev, Munevver Cinar, Lourdes Martinez-Medina, Deon B. Dixie, Li Feng, Pavan Puvvula, Stephen Chang, Leon Bernal-Mizrachi
Journal: Blood
Blood (2023) 142 (Supplement 1): 1937.
https://doi.org/10.1182/blood-2023-188644
Published: 2023
Journal Articles

Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrangement Driven Trial, PINR)

Leon Bernal-Mizrachi, Ajay K. Nooka, Leonard Heffner, Craig E. Cole, Ravi Vij, J Christine Ye, Craig C Hofmeister, John Rushton, Zhengjia Chen, Subir Goyal, Munevver Cinar, Sagar Lonial, Jonathan L. Kaufman
Journal: Blood
Blood (2022) 140 (Supplement 1): 7311–7312.
https://doi.org/10.1182/blood-2022-170062
Published: 2022
Journal Articles

Horizontal Gene Transfer in Multiple Myeloma and Development of a Non-Viral Gene Delivery System

Lourdes Martinez-Medina, Munevver Cinar, Bassel El-Rayes, Ganji Nagaraju, Jean-Michel Gries, Leon Bernal-Mizrachi
Journal: Blood
Blood (2021) 138 (Supplement 1): 3982.
https://doi.org/10.1182/blood-2021-154018
Published: 2021
Journal Articles

Cell Specific Recognition and Capture of Ctdna in Multiple Myeloma

Munevver Cinar, Badri Vardarajan, Neil Anthony, Bassel El-Rayes, Ganji Nagaraju, Lourdes Martinez-Medina, Jean-Michel Gries, Leon Bernal-Mizrachi
Journal: Blood
Blood (2021) 138 (Supplement 1): 1588.
https://doi.org/10.1182/blood-2021-153857
Published: 2021
Journal Articles

Trasposon Mediated Horizontal Gene Transfer (T-HGT) of Circulating Tumor DNA Reshapes MM Clonal Architecture

Munevver Cinar, MD, Steven Flygare, Marina Mosunjac, Ganji Nagaraju, Dongkyoo Park, Sheff Faith, Debra Saxe, PhD, Leon Bernal-Mizrachi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3065.
https://doi.org/10.1182/blood-2019-126699
Published: 2019
Journal Articles

Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrangement Driven Trial, PINR)

Leon Bernal-Mizrachi, MD, Ajay K Nooka, MDMPH, Leonard Heffner, MD, Craig E. Cole, MD, J Christine Ye, MDMSc, Ravi Vij, MBBS, Craig C Hofmeister, MDMPH, John Rushton, PhD, Zhengjia Chen, PhD, Zhao Chang, PhD, Munevver Cinar, MD, Daniel Auclair, Sagar Lonial, Jonathan L. Kaufman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3188.
https://doi.org/10.1182/blood-2019-131223
Published: 2019
Journal Articles

Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrangement Driven Trial, PINR)

Leon Bernal-Mizrachi, MD, Craig E. Cole, MD, Leonard Heffner, MD, Ajay K Nooka, MDMPH, Ravi Vij, MBBS, Nyaya Kelkar, Akshata Sridhar, Munevver Cinar, MD, Zhengjia Chen, PhD, Zhao Chang, PhD, Sagar Lonial, MD, Jonathan L Kaufman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2011.
https://doi.org/10.1182/blood-2018-99-119337
Published: 2018
Journal Articles

Genetic Analysis of Plasmablastic Lymphomas in HIV (+) Patients Reveals Novel Driver Regulators of the Noncanonical NF-κB Pathway

Munevver Cinar, MD, Hsiao-Rong Rong, Iloabueke Chineke, MD, Abner Louissaint, Jr., MD PhD, Jennifer Rose Chapman-Fredricks, MD, Francisco Vega, MD PhD, Clifford James Gunthel, MD, Cassandra Love, Marina Mosunjac, Christopher R Flowers, MDMS, Sandeep Dave, MD, Izidore S. Lossos, MD, Leon Bernal-Mizrachi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1565.
https://doi.org/10.1182/blood-2018-99-118351
Published: 2018